The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience

Abstract Background Treatment for locally recurrent rectal cancer after surgery is still a challenge. With the physical and biological advantages, carbon-ion radiotherapy (CIRT) could be a choice for these patients. The purpose of this study was to investigate the efficacy and safety of CIRT for unr...

Full description

Bibliographic Details
Main Authors: Xin Cai, Yueyao Du, Zheng Wang, Ping Li, Zhan Yu, Qing Zhang, Zhen Zhang
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Radiation Oncology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13014-020-01653-w
id doaj-dfefef41201247a5a000e1a8a4dda54a
record_format Article
spelling doaj-dfefef41201247a5a000e1a8a4dda54a2020-11-25T03:34:51ZengBMCRadiation Oncology1748-717X2020-08-011511810.1186/s13014-020-01653-wThe role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experienceXin Cai0Yueyao Du1Zheng Wang2Ping Li3Zhan Yu4Qing Zhang5Zhen Zhang6Department of Radiation Oncology, Shanghai Proton and Heavy Ion CenterDepartment of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Radiation Oncology, Shanghai Proton and Heavy Ion CenterDepartment of Radiation Oncology, Shanghai Proton and Heavy Ion CenterDepartment of Radiation Oncology, Shanghai Proton and Heavy Ion CenterDepartment of Radiation Oncology, Shanghai Proton and Heavy Ion CenterShanghai Engineering Research Center of Proton and Heavy Ion Radiation TherapyAbstract Background Treatment for locally recurrent rectal cancer after surgery is still a challenge. With the physical and biological advantages, carbon-ion radiotherapy (CIRT) could be a choice for these patients. The purpose of this study was to investigate the efficacy and safety of CIRT for unresectable locally recurrent rectal cancer in Chinese patients. Methods Date from 25 patients with unresectable locally recurrent rectal cancer treated by CIRT from July 2015 to April 2019 were analyzed retrospectively. The endpoints of this study were overall survival (OS), local control (LC) and acute and late toxicity. Results With the median follow-up of 19.6 (range 5.1–52.5) months, data of all 25 patients were collected. Median prescribed dose for tumor was 72Gy (relative biologic efficacy (RBE)) (range 48–75.6Gy (RBE)). The LC rates at 1 and 2 years were 90.4 and 71.8%. Overall LC at 1- and 2-year were 76.2 and 30.5% for 9 patients whose prescribed tumor doses of CIRT< 66 Gy (RBE), 100 and 100% for 16 patients whose prescribed doses of CIRT≥66 Gy (RBE). Patients received ≥66 Gy (RBE) had obviously better LC rates than those received < 66 Gy (RBE) (P = 0.001). The OS rates at 1 and 2 years were 82.9 and 65.1%, respectively. No acute toxicity over grade 2 was observed, grade 3 late toxicity were observed in 3 patients: gastrointestinal toxicity (n = 1), neuropathy (n = 1), pelvic infection (n = 1). No Grade 4 or higher toxicity was observed. Conclusion Our study shows that CIRT is effective for unresectable locally recurrent rectal cancer patients with acceptable toxicity.http://link.springer.com/article/10.1186/s13014-020-01653-wCarbon-ionRectal cancerPelvic radiationLocal recurrenceParticle therapy
collection DOAJ
language English
format Article
sources DOAJ
author Xin Cai
Yueyao Du
Zheng Wang
Ping Li
Zhan Yu
Qing Zhang
Zhen Zhang
spellingShingle Xin Cai
Yueyao Du
Zheng Wang
Ping Li
Zhan Yu
Qing Zhang
Zhen Zhang
The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience
Radiation Oncology
Carbon-ion
Rectal cancer
Pelvic radiation
Local recurrence
Particle therapy
author_facet Xin Cai
Yueyao Du
Zheng Wang
Ping Li
Zhan Yu
Qing Zhang
Zhen Zhang
author_sort Xin Cai
title The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience
title_short The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience
title_full The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience
title_fullStr The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience
title_full_unstemmed The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience
title_sort role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience
publisher BMC
series Radiation Oncology
issn 1748-717X
publishDate 2020-08-01
description Abstract Background Treatment for locally recurrent rectal cancer after surgery is still a challenge. With the physical and biological advantages, carbon-ion radiotherapy (CIRT) could be a choice for these patients. The purpose of this study was to investigate the efficacy and safety of CIRT for unresectable locally recurrent rectal cancer in Chinese patients. Methods Date from 25 patients with unresectable locally recurrent rectal cancer treated by CIRT from July 2015 to April 2019 were analyzed retrospectively. The endpoints of this study were overall survival (OS), local control (LC) and acute and late toxicity. Results With the median follow-up of 19.6 (range 5.1–52.5) months, data of all 25 patients were collected. Median prescribed dose for tumor was 72Gy (relative biologic efficacy (RBE)) (range 48–75.6Gy (RBE)). The LC rates at 1 and 2 years were 90.4 and 71.8%. Overall LC at 1- and 2-year were 76.2 and 30.5% for 9 patients whose prescribed tumor doses of CIRT< 66 Gy (RBE), 100 and 100% for 16 patients whose prescribed doses of CIRT≥66 Gy (RBE). Patients received ≥66 Gy (RBE) had obviously better LC rates than those received < 66 Gy (RBE) (P = 0.001). The OS rates at 1 and 2 years were 82.9 and 65.1%, respectively. No acute toxicity over grade 2 was observed, grade 3 late toxicity were observed in 3 patients: gastrointestinal toxicity (n = 1), neuropathy (n = 1), pelvic infection (n = 1). No Grade 4 or higher toxicity was observed. Conclusion Our study shows that CIRT is effective for unresectable locally recurrent rectal cancer patients with acceptable toxicity.
topic Carbon-ion
Rectal cancer
Pelvic radiation
Local recurrence
Particle therapy
url http://link.springer.com/article/10.1186/s13014-020-01653-w
work_keys_str_mv AT xincai theroleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience
AT yueyaodu theroleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience
AT zhengwang theroleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience
AT pingli theroleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience
AT zhanyu theroleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience
AT qingzhang theroleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience
AT zhenzhang theroleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience
AT xincai roleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience
AT yueyaodu roleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience
AT zhengwang roleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience
AT pingli roleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience
AT zhanyu roleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience
AT qingzhang roleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience
AT zhenzhang roleofcarbonionradiotherapyforunresectablelocallyrecurrentrectalcancerasingleinstitutionalexperience
_version_ 1724557079988928512